OPPM
Opus Point Partners Management Portfolio holdings
AUM
$46.9M
1-Year Return
4.17%
This Quarter Return
+19.96%
1 Year Return
-4.17%
3 Year Return
+83.22%
5 Year Return
+175.29%
10 Year Return
–
AUM
$99M
AUM Growth
–
Cap. Flow
+$99M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
38.62%
Holding
52
New
50
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
ProShares Ultra NASDAQ Biotechnology
BIB
|
$4.79M |
| 2 |
Incyte
INCY
|
$4.45M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
$3.95M |
| 4 |
SPDR S&P Biotech ETF
XBI
|
$3.88M |
| 5 |
CELG
Celgene Corp
CELG
|
$3.7M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 71.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Exact Sciences
EXAS
$9.73B
| – | – |
0
| – | – |
|